Accumulation and Endocrine Disrupting Effects of the Flame Retardant Mixture Firemaster® 550 in Rats: An Exploratory Assessment

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 2, 2013, Pages 124-136

  Patisaul, Heather B ^a   Roberts, Simon C ^b   Mabrey, Natalie ^a   Mccaffrey, Katherine A ^a   Gear, Robin B ^c   Braun, Joe ^d   Belcher, Scott M ^c   Stapleton, Heather M ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Anxiety; Cardiac Hypertrophy; Endocrine Disruptor; Flame Retardants; Metabolic Syndrome; Metabolism; Obesity; Obesogen; Polybrominated Diphenyl Ethers; Rodents

Indexed keywords

ENDOCRINE DISRUPTOR; FLAME RETARDANT; LIVER ENZYME; THYROXINE;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; FEMALE; HEART VENTRICLE HYPERTROPHY; LACTATION; MALE; METABOLIC SYNDROME X; NONHUMAN; PHENOTYPE; PROGENY; RAT; THYROXINE BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; CARDIOMEGALY; ENDOCRINE SYSTEM; FEMALE; FLAME RETARDANTS; MALE; MATERNAL EXPOSURE; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; THYROXINE;

RATTUS; RODENTIA;

EID: 84874018579     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21439     Document Type: Article

References (53)

1. Birnbaum LS, Staskal DF. Brominated flame retardants: cause for concern? Environ Health Perspect 2004;112(1):9-17.
2. UNEP. Stockholm convention on persistent organic pollutants. Nairobi, Kenya: United Nations Environmental Programme; 2001.
3. EPA. Furniture flame retardancy partnership: environmental profiles of chemical flame retardant alternatives. EPA 742-R-05-002A; 2005.
4. Stapleton HM, Allen JG, Kelly SM, Konstantinov A, Klosterhaus S, Watkins D, McClean MD, Webster TF. Alternate and new brominated flame retardants detected in U.S. house dust. Environ Sci Technol 2008;42(18):6910-6916.
5. Stapleton HM, Klosterhaus S, Keller A, Ferguson PL, van Bergen S, Cooper E, Webster TF, Blum A. Identification of flame retardants in polyurethane foam collected from baby products. Environ Sci Technol 2011;45(12):5323-5331.
6. Ma Y, Venier M, Hites RA. 2-Ethylhexyl tetrabromobenzoate and bis(2-ethylhexyl) tetrabromophthalate flame retardants in the Great Lakes atmosphere. Environ Sci Technol 2012;46(1):204-208.
7. Lam JCW, Lau RKF, Murphy MB, Lam PKS. Temporal trends of hexabromocyclododecanes (HBCDs) and polybrominated diphenyl ethers (PBDEs) and detection of two novel flame retardants in marine mammals from Hong Kong, South China. Environ Sci Technol 2009;43(18):6944-6949.
8. La Guardia MJ, Hale RC, Harvey E, Chen D. Flame-retardants and other organohalogens detected in sewage sludge by electron capture negative ion mass spectrometry. Environ Sci Technol 2010;44(12):4658-4664.
9. Davis EF, Klosterhaus SL, Stapleton HM. Measurement of flame retardants and triclosan in municipal sewage sludge and biosolids. Environ Int 2012;40:1-7.
10. USEPA. Tracking progress on U.S. EPA's polybrominated diphenyl ether (PBDEs) project plan: Status report on key activities. In: USEPA, editor. Volume Accessed June 2012; 2008. http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/pbdestatus1208.pdf.
11. Stapleton HM, Eagle S, Sjodin A, Webster TF. Serum PBDEs in a North Carolina toddler cohort: associations with hand wipes, house dust and socioeconomic variables. Environ Health Perspect 2012;120(7):1049-1054.
12. Roberts SC, Macaulay LJ, Stapleton HM. In vitro metabolism of the brominated flame retardants 2-ethylhexyl-2, 3, 4, 5-tetrabromobenzoate (TBB) and bis(2-ethylhexyl) 2, 3, 4, 5-tetrabromophthalate (TBPH) in human and rat tissues. Chem Res Toxicol 2012; 16;25(7):1435-1441.
13. Thigpen JE, Setchell KDR, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, Forsythe DB. Phytoestrogen content of purified open- and closed-formula laboratory animal diets. Lab Anim Sci 1999;49(5):530-536.
14. Hunt PA, Koehler KE, Susiarjo M, Hodges CA, Ilagan A, Voigt RC, Thomas S, Thomas BF, Hassold TJ. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr Biol 2003;13(7):546-553.
15. Kalinichev M, Easterling KW, Plotsky PM, Holtzman SG. Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats. Pharmacol Biochem Behav 2002;73(1):131-140.
16. Palanza P, Gioiosa L, vom Saal FS, Parmigiani S. Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ Res 2008;108(2):150-157.
17. Cox KH, Gatewood JD, Howeth C, Rissman EF. Gestational exposure to bisphenol A and cross-fostering affect behaviors in juvenile mice. Horm Behav 2010;58(5):754-761.
18. Stapleton HM, Brazil B, Holbrook RD, Mitchelmore CL, Benedict R, Konstantinov A, Potter D. In vivo and in vitro debromination of decabromodiphenyl ether (BDE 209) by juvenile rainbow trout and common carp. Environ Sci Technol 2006;40(15):4653-4658.
19. Wang DL, Stapleton HM. Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2010;397(5):1831-1839.
20. Butt CM, Wang D, Stapleton HM. Halogenated phenolic contaminants inhibit the in vitro activity of the thyroid-regulating deiodinases in human liver. Toxicol Sci 2011;124(2):339-347.
21. Wheelock CE, Severson TF, Hammock BD. Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility. Chem Res Toxicol 2001;14(12):1563-1572.
22. Ojeda SR, Wheaton JE, Jameson HE, McCann SM. The onset of puberty in the female rat: changes in plasma prolactin, gonadotropins, luteinizing hormone-releasing hormone (LHRH), and hypothalamic LHRH content. Endocrinology 1976;98(3):630-638.
23. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996;54(1):21-30.
24. Patisaul HB, Bateman HL. Neonatal exposure to endocrine active compounds or an ERb agonist increases adult anxiety and aggression in gonadally intact male rats. Horm Behav 2008;53(4):580-588.
25. Patisaul HB, Blum A, Luskin JR, Wilson ME. Dietary soy supplements produce opposite effects on anxiety in intact male and female rats in the elevated plus-maze. Behav Neurosci 2005;119(2):587-594.
26. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14(3):149-167.
27. Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, Herman JP, Marts S, Sadee W, Steiner M, Steiner M, Taylor J, Young E. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005;146(4):1650-1673.
28. Haseman JK, Bailer AJ, Kodell RL, Morris R, Portier K. Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 2001;61(2):201-210.
29. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal data analysis. Hoboken, NJ: Wiley; 2004.
30. Vazzana N, Santilli F, Sestili S, Cuccurullo C, Davi G. Determinants of increased cardiovascular disease in obesity and metabolic syndrome. Curr Med Chem 2011;18(34):5267-5280.
31. Prasad H, Ryan DA, Celzo MF, Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad Med 2012;124(1):21-30.
32. Lim JS, Lee DH, Jacobs DR, Jr. Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004. Diabetes Care 2008;31(9):1802-1807.
33. Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 2011;73:135-162.
34. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, Hasemeier CM. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 1997;99(4):505-512.
35. Partsch CJ, Sippell WG. Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update 2001;7(3):292-302.
36. Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 2009;123(5):e932-e939.
37. Proos LA, Hofvander Y, Tuvemo T. Menarcheal age and growth pattern of Indian girls adopted in Sweden. I. Menarcheal age. Acta Paediatr Scand 1991;80(8-9):852-588.
38. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003;24(5):668-693.
39. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature 1999;401(6755):763-764.
40. Foster PM, McIntyre BS. Endocrine active agents: implications of adverse and non-adverse changes. Toxicol Pathol 2002;30(1):59-65.
41. Zhu HJ, Pan H, Zhang DX, Wu QY, Zhang K, Li M, Gong FY, Wu XY, Deng JY, Shi YF. Effect of bodyweight on the onset of puberty of female children and adolescents. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2010;32(1):25-28 (in Chinese).
42. Zhou T, Ross DG, DeVito MJ, Crofton KM. Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol Sci 2001;61(1):76-82.
43. Szabo DT, Richardson VM, Ross DG, Diliberto JJ, Kodavanti PRS, Birnbaum LS. Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. Toxicol Sci 2009;107(1):27-39.
44. Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol 2011;54(3):478-487.
45. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V, Vichayanrat A. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxford) 2001;54(3):365-370.
46. Papendieck P, Chiesa A, Prieto L, Gruneiro-Papendieck L. Thyroid disorders of neonates born to mothers with Graves' disease. J Pediatr Endocrinol Metab 2009;22(6):547-553.
47. Stagnaro-Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 2009;94(1):21-25.
48. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxford) 1984;20(6):695-700.
49. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 1992;80(3, Pt 1):359-364.
50. Zhang L, Hernandez VS, Medina-Pizarro M, Valle-Leija P, Vega-Gonzalez A, Morales T. Maternal hyperthyroidism in rats impairs stress coping of adult offspring. J Neurosci Res 2008;86(6):1306-1315.
51. Jernas M, Olsson B, Arner P, Jacobson P, Sjostrom L, Walley A, Froguel P, McTernan PG, Hoffstedt J, Carlsson LM. Regulation of carboxylesterase 1 (CES1) in human adipose tissue. Biochem Biophys Res Commun 2009;383(1):63-67.
52. Xu X, Tian D, Hong X, Chen L, Xie L. Sex-specific influence of exposure to bisphenol-A between adolescence and young adulthood on mouse behaviors. Neuropharmacology 2011;61(4):565-573.
53. Wolstenholme JT, Rissman EF, Connelly JJ. The role of bisphenol A in shaping the brain, epigenome and behavior. Horm Behav 2011;59(3):296-305.